ng-nitroarginine methyl ester has been researched along with Colonic Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gustafsson, SB; Jacobsson, SO; Jonsson, M; Lindgren, T | 1 |
| Alexandre, J; Annereau, M; Batteux, F; Chéreau, C; Dauphin, A; Goldwasser, F; Lemare, F; Mongaret, C; Nicco, C; Thomas-Schoemann, A; Weill, B | 1 |
| Jeannin, JF; Onier-Cherix, N; Reisser, D | 1 |
| Handa, O; Higashihara, H; Inoue, M; Ishikawa, T; Kokura, S; Naito, Y; Okanoue, T; Takagi, T; Uchiyama, K; Yoshida, N; Yoshikawa, T | 1 |
| Liang, G; Lonigro, AJ; Sprague, RS; Stephenson, AH | 1 |
| Badn, W; Kalliomäki, S; Sjögren, HO; Widegren, B | 1 |
| Backman, V; Goldberg, MJ; Hart, J; Kim, Y; Koetsier, JL; Kunte, DP; Liu, Y; Roy, HK; Wali, RK | 1 |
| Eckmann, L; Kagnoff, MF; Kim, JM; Witthöft, T | 1 |
| Kawamori, T; Nakatsugi, S; Ohta, T; Sugimura, T; Takahashi, M; Wakabayashi, K; Watanabe, K | 1 |
| Bernstein, C; Bernstein, H; Hoglen, N; Payne, CM; Washo-Stultz, D | 1 |
| Kawamori, T; Nakatsugi, S; Wakabayashi, K; Watanabe, K | 1 |
| Hegardt, P; Kjellman, C; Li, L; Sjögren, B; Sjögren, HO; Sur, I; Widegren, B | 1 |
| Andrade, SP; Hart, IR; Piper, PJ | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Colonic Neoplasms
| Article | Year |
|---|---|
COX-2 and iNOS, good targets for chemoprevention of colon cancer.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Humans; Isoenzymes; Membrane Proteins; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Rats; Receptors, Prostaglandin E; Sulfonamides | 2000 |
12 other study(ies) available for ng-nitroarginine methyl ester and Colonic Neoplasms
| Article | Year |
|---|---|
Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antioxidants; Cannabinoid Receptor Antagonists; Cannabinoids; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclic AMP; Dronabinol; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Fatty Acids, Unsaturated; Fluorouracil; Humans; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Piperidines; Pyrazoles; Receptors, Cannabinoid; Thymidine; Tumor Cells, Cultured | 2009 |
Arsenic trioxide exerts antitumor activity through regulatory T cell depletion mediated by oxidative stress in a murine model of colon cancer.
Topics: Animals; Arsenic Trioxide; Arsenicals; CD8-Positive T-Lymphocytes; Colonic Neoplasms; Enzyme Inhibitors; Female; Fluorescein; Fluoresceins; Humans; Immunotherapy, Adoptive; Lymphocyte Activation; Lymphocyte Depletion; Metalloporphyrins; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxidative Stress; Oxides; Reactive Nitrogen Species; Reactive Oxygen Species; Superoxide Dismutase; T-Lymphocytes, Regulatory | 2012 |
Arginase activity is inhibited by L-NAME, both in vitro and in vivo.
Topics: Animals; Arginase; Colonic Neoplasms; Dose-Response Relationship, Drug; Enzyme Inhibitors; Liver; Neoplasm Proteins; NG-Nitroarginine Methyl Ester; Rats; Treatment Outcome; Tumor Cells, Cultured | 2002 |
Different effects of constitutive nitric oxide synthase and heme oxygenase on pulmonary or liver metastasis of colon cancer in mice.
Topics: Animals; Carbon Monoxide; Colonic Neoplasms; Deuteroporphyrins; Heme Oxygenase (Decyclizing); Liver; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Neoplasm Transplantation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Platelet Aggregation; Time Factors; Tumor Cells, Cultured | 2003 |
Erythrocytes of humans with cystic fibrosis fail to stimulate nitric oxide synthesis in isolated rabbit lungs.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Enzyme Inhibitors; Erythrocyte Membrane; Erythrocytes; Humans; In Vitro Techniques; Lung; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pulmonary Circulation; Rabbits; Sodium Chloride | 2005 |
Low-dose combretastatin A4 phosphate enhances the immune response of tumor hosts to experimental colon carcinoma.
Topics: Administration, Oral; Animals; Carcinoma; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; Humans; Injections, Intraperitoneal; Interferon-gamma; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred BN; Rats, Inbred WF; Stilbenes; Structure-Activity Relationship; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2006 |
Inducible nitric oxide synthase (iNOS) mediates the early increase of blood supply (EIBS) in colon carcinogenesis.
Topics: Animals; Azoxymethane; Carcinogens; Colonic Neoplasms; Enzyme Inhibitors; Immunohistochemistry; Light; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type II; Rats; Rats, Inbred F344; Scattering, Radiation; Time Factors | 2007 |
Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells.
Topics: Adenocarcinoma; Cell Line; Colon; Colonic Neoplasms; Escherichia coli; Gene Expression Regulation, Enzymologic; Humans; Intestinal Mucosa; Kinetics; Lipopolysaccharides; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Polymerase Chain Reaction; RNA, Messenger; Salmonella; Shigella flexneri; Time Factors; Transcription, Genetic; Tumor Cells, Cultured | 1998 |
Suppression of azoxymethane-induced colonic aberrant crypt foci by a nitric oxide synthase inhibitor.
Topics: Animals; Anticarcinogenic Agents; Antigens, Nuclear; Azoxymethane; Body Weight; Carcinogens; Cell Division; Cell Nucleus; Colon; Colonic Neoplasms; Intestinal Mucosa; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nuclear Proteins; Precancerous Conditions; Rats; Rats, Inbred F344 | 2000 |
Role of nitric oxide and peroxynitrite in bile salt-induced apoptosis: relevance to colon carcinogenesis.
Topics: Apoptosis; Bile Acids and Salts; Colonic Neoplasms; Deoxycholic Acid; Enzyme Inhibitors; Fluorescent Antibody Technique; Free Radical Scavengers; Humans; Microscopy, Confocal; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Salicylates; Superoxides; Tumor Cells, Cultured; Tyrosine | 1999 |
Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma.
Topics: Adenocarcinoma; Animals; Cell Survival; Colonic Neoplasms; Cytokines; Dendritic Cells; DNA, Complementary; Enzyme Inhibitors; Female; Immunity, Cellular; Interferon-gamma; Interleukin-18; Macrophages; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred BN; Rats, Wistar; RNA; Spleen; Tumor Cells, Cultured | 2001 |
Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature.
Topics: Adenocarcinoma; Amino Acid Oxidoreductases; Animals; Arginine; Colonic Neoplasms; Male; Melanoma, Experimental; Methylene Blue; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostheses and Implants; Regional Blood Flow | 1992 |